← Open Payments lookup

MEAGAN GILBERT: Open Payments

NPI 1457753410 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,893 in 122 payments from 19 companies in 2025. Trend: 2023 $1,104 · 2024 $2,198 · 2025 $2,893

Food & beverage: $2,809Education: $84
CompanyPaymentsAmount
Janssen Biotech, Inc.19$656
ABBVIE INC.21$534
Takeda Pharmaceuticals U.S.A., Inc.18$389
Madrigal Pharmaceuticals6$164
GENZYME CORPORATION6$147
Aimmune Therapeutics, Inc.7$137
Phathom Pharmaceuticals, Inc.6$132
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$118
Regeneron Healthcare Solutions, Inc.5$114
Celltrion USA Inc.5$101

Products named: TREMFYA, ENTYVIO, RINVOQ, SKYRIZI, DUPIXENT, REZDIFFRA, VOQUEZNA, XIFAXAN.

Industry payments across TX — which companies pay providers there.